Take One: Big story of the day
-
OTT platforms ask for more time to comply, MIB remains non-committal
Industry seeks more clarity, expresses concerns about newly notified Digital Media Code of Ethics in a closed-door meeting with the minister
-
Razorpay's 'full stack' ambition
The fintech unicorn has gone beyond payments into neobanking and facilitating loans and insurance. The dream is to become the only financial platform a business will ever need
-
Krishna Ella: How a farmer's son gave India its first successful indigenous Covid-19 vaccine
As Bharat Biotech's Covaxin shows an interim efficacy of 81 percent, Forbes India traces the career of the founder, whose entrepreneurial journey has seen a successful track record of developing vaccines in India for the world
-
India's first woman airline CEO has ambitious goals. Can she take off?
The first woman pilot hired by Air India, Harpreet A De Singh is now charged with turning around the fortunes of its subsidiary Alliance Air
-
The IPO routes for India's internet unicorns
Will Sebi's new recommendations make public listings easier for India's internet-based startups?
-
Rising inflation could stand in the way of India's economic recovery
If inflation proves to be sticky, rising costs of capital for the government, companies and individuals could also restrict infrastructure spending and slow down private sector capex cycle
-
Can private sector involvement in Covid-19 vaccination starting March 1 make a difference?
As the government prepares to vaccinate senior citizens and persons with comorbidities, Forbes India deconstructs the immunisation plan and looks at how private sector involvement can speed up the current laggard pace of Covid-19 vaccinations
-
TaxiForSure's Raghunandan returns to entrepreneurship with a cross-border neobank
Six years after exiting his ride-hailing service venture, he starts Zolve—a branchless digital banking services provider—that offers local access to credit and insurance at affordable rates to those who traverse the globe
-
Inside Dr Reddy's plan to become India's third Covid-19 vaccine maker
Nearly six months after it struck a deal with Russia's Gamaleya National Research Institute of Epidemiology and Microbiology, the company is awaiting permission to administer the Sputnik V vaccine in India
-
Kamesh Goyal: Roaring in the fifties with a $1.9 billion valuation
How, at 55, the founder of Digit Insurance built a unicorn in three years
-
How Guenter Butschek steered Tata Motors' India car business out of its misery
The MD & CEO, who will relocate to Germany later this year, turned around the fortunes of the company by ensuring a diversified portfolio, launching attractive products, and addressing quality and cost issues